Side-effects of hormone replacement therapy and influence on pattern of use among women 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 9, 2004, Pages 850-856

  Bakken, Kjersti ^a   Eggen, Anne Elise ^a   Lund, Eiliv ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Dosage; Hormone replacement therapy; Pattern of use; Side effects; Weight gain

Indexed keywords

HORMONE;

ADULT; ARTICLE; BLEEDING; BREAST TENDERNESS; CONTROLLED STUDY; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NAUSEA; OSTEOPOROSIS; POPULATION RESEARCH; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; WEIGHT GAIN;

ADULT; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; NORWAY; ODDS RATIO; OSTEOPOROSIS; PATIENT COMPLIANCE; PROBABILITY; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT REFUSAL; WEIGHT GAIN;

EID: 4444237119     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00560.x     Document Type: Article

References (41)

1. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977; 4: 31-47.
2. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
3. Michaelsson K, Baron JA, Farahmand BY, Johnell O, Magnusson C, Persson PG et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. Br Med J 1998; 316: 1858-63.
4. Mosca L. The role of hormone replacement therapy in the prevention of postmenopausal heart disease. Arch Intern Med 2000; 160: 2263-72.
5. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. J Am Med Assoc 2001; 285: 1489-99.
6. Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas 2001; 40: 131-41.
7. Andersson K, Pedersen AT, Mattsson LA, Milsom I. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies. Acta Obstet Gynecol Scand 1998; 77: 909-16.
8. Hemminki E, Topo P. Prescribing of hormone therapy in menopause and postmenopause. J Psychosom Obstet Gynaecol 1997; 18: 145-57.
9. Nilsen ST, Fredriksen T, Iversen OE, Moen MH. [Attitude to and practice of Norwegian gynecologists concerning hormone replacement therapy in the climacteric.] Tidsskr Nor Laegeforen 1998; 118: 2940-3.
10. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993; 329: 1141-6.
11. Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999; 6: 282-9.
12. Coope J, Marsh J. Can we improve compliance with long-term HRT? Maturitas 1992; 15: 151-8.
13. Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J, Bergman U. Low use of long-term hormone replacement therapy in Denmark. Br J Clin Pharmacol 1999; 47: 323-8.
14. Ravnikar VA. Hormonal management of osteoporosis. Clin Obstet Gynecol 1992; 35: 913-22.
15. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321-33.
16. Nand SL, Webster MA, Baber R, Heller GZ. Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group. Climacteric 1998; 1: 211-68.
17. Vihtamaki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999; 33: 99-105.
18. Lund E, Kumle M, Braaten T, Hjartaker A, Bakken K, Eggen A et al. External validity in a population based national prospective study - The Norwegian Women and Cancer study (NOWAC). Cancer Causes Control 2003; 14: 1001-8.
19. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner. J. The person-number system of Sweden, Norway, Denmark and Israel. Vital Health Stat 2 1980; 84: 1-59.
20. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 2000; 7: 273-81.
21. Ballard K. Women's use of hormone replacement therapy for disease prevention; results of a community survey. Br J Gen Pract 2002; 52: 835-7.
22. Groeneveld FP, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Duration of hormonal replacement therapy in general practice; a follow-up study. Maturitas 1998; 29: 125-31.
23. Wren BG, Brown L. Compliance with hormonal replacement therapy. Maturitas 1991; 13: 17-21.
24. den Tonkelaar I, Oddens BJ. Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol 2000; 95: 507-12.
25. ESHRE-group GT. Continuation rates for oral contraceptives and hormone replacement therapy. The ESHRE Capri Workshop Group. Hum Reprod 2000; 15: 1865-71.
26. Collaborators MWS. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. Br J Obstet Gynaecol 2002; 109: 1319-30.
27. Kenemans P, van Unnik GA, Mijatovic V, van der Mooren MJ. Perspectives in hormone replacement therapy. Maturitas 2001; 38: S41-8.
28. Bjorn I, Backsrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999; 32: 77-86.
29. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Jones M et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab 2000; 11: 184-8.
30. Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 2003; 18: 333-42.
31. van Seumeren I. Weight gain and hormone replacement therapy: are women's fears justified? Maturitas 2000; 34: S3-8.
32. Gower BA, Nagy TR, Goran MI, Smith A, Kent E. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 2000; 85: 1770-5.
33. Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri- menopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000; 2.
34. Schneider HP, Gallagher JC. Moderation of the daily dose of HRT: benefits for patients. Maturitas 1999; 33: S25-9.
35. Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998; 105: 904-11.
36. Lund E, Gram IT. Response rate according to title and length of questionnaire. Scand J Soc Med 1998; 26: 154-60.
37. Brogger J, Bakke P, Eide GE, Gulsvik A. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. Am J Epidemiol 2003; 157: 558-66.
38. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 942-4.
39. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-34.
40. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27.
41. Norwegian Institute of Public Health. http://www.fhi.no/ 2004.